{
  "@context": {
    "fabio": "http://purl.org/spar/fabio/",
    "dcterms": "http://purl.org/dc/terms/",
    "foaf": "http://xmlns.com/foaf/0.1/",
    "cito": "http://purl.org/spar/cito/",
    "doco": "http://purl.org/spar/doco/",
    "pro": "http://purl.org/spar/pro/",
    "obi": "http://purl.obolibrary.org/obo/",
    "schema": "http://schema.org/"
  },
  "@type": "fabio:ResearchPaper",
  "obi:OBI_0000299": [
    {
      "@id": "http://purl.obolibrary.org/obo/GO_0006915",
      "obi:BFO_0000050": {
        "@id": "http://purl.obolibrary.org/obo/GO_0012501",
        "dcterms:description": "MCL1 and JUNB modulate the mitochondrial apoptosis pathway to mediate resistance to FasL- and TRAIL-induced cell death"
      }
    },
    {
      "@id": "http://purl.obolibrary.org/obo/GO_0042110",
      "obi:RO_0002304": {
        "@id": "http://purl.obolibrary.org/obo/GO_0006955",
        "dcterms:description": "B3GNT2 affects T cell activation through glycosylation modifications of cell surface proteins"
      }
    },
    {
      "@id": "http://purl.obolibrary.org/obo/GO_0006486",
      "obi:RO_0002304": {
        "@id": "http://purl.obolibrary.org/obo/GO_0007166",
        "dcterms:description": "B3GNT2 adds poly-LacNAc modifications to multiple cell surface receptors affecting their signaling capabilities"
      }
    },
    {
      "@id": "http://purl.obolibrary.org/obo/GO_0008219",
      "obi:BFO_0000066": {
        "@id": "http://purl.obolibrary.org/obo/GO_0071228",
        "dcterms:description": "The paper examines mechanisms of T cell-mediated cytotoxicity against tumor cells"
      }
    },
    {
      "@id": "http://purl.obolibrary.org/obo/GO_0071159",
      "obi:RO_0002304": {
        "@id": "http://purl.obolibrary.org/obo/GO_0006955",
        "dcterms:description": "JUNB activates the NF-κB pathway which affects immune response through regulation of multiple target genes"
      }
    },
    {
      "@id": "http://purl.obolibrary.org/obo/DOID_1909",
      "dcterms:title": "melanoma",
      "dcterms:description": "Study found that overexpression of CD274 (PD-L1), MCL1, JUNB, and B3GNT2 enables melanoma cells to evade T cell killing. MCL1 and JUNB modulate mitochondrial apoptosis pathway, while B3GNT2 disrupts tumor-T cell interactions through glycosylation modifications."
    },
    {
      "@id": "http://purl.obolibrary.org/obo/DOID_3908",
      "dcterms:title": "non-small cell lung cancer",
      "dcterms:description": "Research demonstrated that CD274, MCL1, JUNB and B3GNT2 confer resistance to T cell cytotoxicity in non-small cell lung cancer cells, with MCL1 and B3GNT2 showing broad applicability across different cancer types."
    },
    {
      "@id": "http://purl.obolibrary.org/obo/DOID_0050861",
      "dcterms:title": "colorectal adenocarcinoma",
      "dcterms:description": "Study showed that knockdown of CD274, MCL1, JUNB and B3GNT2 significantly decreased cancer cell survival when exposed to T cells, with B3GNT2 showing particularly high expression in this cancer type."
    },
    {
      "@id": "http://purl.obolibrary.org/obo/DOID_4074",
      "dcterms:title": "pancreatic adenocarcinoma",
      "dcterms:description": "Chemical inhibition of MCL1 and B3GNT2 reduced survival of patient-derived pancreatic adenocarcinoma cells against T cell cytotoxicity, suggesting potential therapeutic applications."
    },
    {
      "@id": "http://purl.obolibrary.org/obo/DOID_3605",
      "dcterms:title": "ovarian cystadenocarcinoma",
      "dcterms:description": "Knockdown of MCL1 and JUNB decreased cell survival in ovarian cystadenocarcinoma cells when exposed to T cell cytotoxicity."
    },
    {
      "@id": "http://purl.obolibrary.org/obo/CHEBI_26174",
      "dcterms:title": "poly-N-acetyllactosamine",
      "dcterms:description": "B3GNT2 increases poly-N-acetyllactosamine on at least ten tumor ligands and receptors to reduce T cell activation. B3GNT2 has the strongest poly-LacNAc synthesis activity compared to other B3GNT enzymes and is considered the main poly-N-acetyllactosamine synthase."
    },
    {
      "@id": "http://purl.obolibrary.org/obo/CHEBI_5939",
      "dcterms:title": "interferon gamma",
      "dcterms:description": "B3GNT2 and CD274 overexpression reduced interferon gamma secretion by T cells. CD274 reduced tumor response to interferon gamma through reduced phosphorylation of STAT1."
    },
    {
      "@id": "http://purl.obolibrary.org/obo/CHEBI_197440",
      "dcterms:title": "tumor necrosis factor alpha",
      "dcterms:description": "Cells were challenged with TNF-α to test cytokine responses. Loss-of-function genetic screens identified tumor necrosis factor pathway as important for mediating resistance to T cell-induced cytotoxicity."
    },
    {
      "@id": "http://purl.obolibrary.org/obo/CHEBI_18085",
      "dcterms:title": "glycosaminoglycan",
      "dcterms:description": "Pathway analysis revealed glycosaminoglycan metabolism was significantly enriched among resistance mediators, suggesting an underappreciated role in regulating tumor response to T cell cytotoxicity."
    }
  ],
  "cito:cites": [
    {
      "@id": "https://doi.org/10.1056/NEJMoa1606774",
      "dcterms:title": "Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer"
    },
    {
      "@id": "https://doi.org/10.1038/nature21349",
      "dcterms:title": "Elements of cancer immunity and the cancer-immune set point"
    },
    {
      "@id": "https://doi.org/10.1016/j.immuni.2019.12.011",
      "dcterms:title": "Top 10 challenges in cancer immunotherapy"
    },
    {
      "@id": "https://doi.org/10.1056/NEJMoa1604958",
      "dcterms:title": "Mutations associated with acquired resistance to PD-1 blockade in melanoma"
    },
    {
      "@id": "https://doi.org/10.1038/nm730",
      "dcterms:title": "Tumor-associated B7-H1 promotes T-cell apoptosis a potential mechanism of immune evasion"
    },
    {
      "@id": "https://doi.org/10.1084/jem.20130066",
      "dcterms:title": "Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4"
    },
    {
      "@id": "https://doi.org/10.1016/S1074-7613(03)00152-3",
      "dcterms:title": "B7-H4, a molecule of the B7 family, negatively regulates T cell immunity"
    },
    {
      "@id": "https://doi.org/10.1073/pnas.1305569110",
      "dcterms:title": "Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response"
    },
    {
      "@id": "https://doi.org/10.1056/NEJMoa1302369",
      "dcterms:title": "Nivolumab plus ipilimumab in advanced melanoma"
    },
    {
      "@id": "https://doi.org/10.1038/s41586-020-2746-2",
      "dcterms:title": "Functional genomic landscape of cancer-intrinsic evasion of killing by T cells"
    }
  ],
  "@id": "https://doi.org/10.1038/s41467-022-29056-4",
  "dcterms:hasPart": "Research focused on multiple molecular mechanisms involved in cancer cell resistance to T cell mediated cytotoxicity The study identified several key pathways and molecules MCL1 and JUNB were found to modulate the mitochondrial apoptosis pathway conferring resistance to FasL and TRAIL induced cell death B3GNT2 affects T cell activation through glycosylation modifications of cell surface proteins adding poly LacNAc modifications to multiple receptors and impacting their signaling capabilities JUNB activates the NF kB pathway which influences immune response through regulation of multiple target genes The research examined various cancer types including melanoma where overexpression of CD274 MCL1 JUNB and B3GNT2 enables cancer cells to evade T cell killing In non small cell lung cancer these same molecules confer resistance to T cell cytotoxicity with MCL1 and B3GNT2 showing broad applicability across different cancer types Knockdown studies in colorectal adenocarcinoma demonstrated that targeting CD274 MCL1 JUNB and B3GNT2 significantly decreased cancer cell survival when exposed to T cells Chemical inhibition of MCL1 and B3GNT2 reduced survival of patient derived pancreatic adenocarcinoma cells while knockdown of MCL1 and JUNB decreased cell survival in ovarian cystadenocarcinoma cells B3GNT2 increases poly N acetyllactosamine on multiple tumor ligands and receptors reducing T cell activation and is considered the main poly N acetyllactosamine synthase B3GNT2 and CD274 overexpression reduced interferon gamma secretion by T cells with CD274 reducing tumor response through decreased STAT1 phosphorylation Loss of function genetic screens identified the tumor necrosis factor pathway as crucial for mediating resistance to T cell induced cytotoxicity Pathway analysis revealed glycosaminoglycan metabolism was significantly enriched among resistance mediators suggesting an important role in regulating tumor response to T cell cytotoxicity",
  "schema:relatedTo": [
    {
      "@id": "did:dkg:base:84532/0xd5550173b0f7b8766ab2770e4ba86caf714a5af5/101962",
      "@type": "schema:Organization",
      "schema:name": "CryoDAO"
    },
    {
      "@id": "did:dkg:base:84532/0xd5550173b0f7b8766ab2770e4ba86caf714a5af5/101963",
      "@type": "schema:Organization",
      "schema:name": "Cerebrum DAO"
    }
  ]
}